These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 31466607)
1. Advances in T-cell Immunotherapies. Stroncek DF; Reddy O; Highfill S; Panch SR Hematol Oncol Clin North Am; 2019 Oct; 33(5):825-837. PubMed ID: 31466607 [TBL] [Abstract][Full Text] [Related]
2. Principles of adoptive T cell therapy in cancer. Met Ö; Jensen KM; Chamberlain CA; Donia M; Svane IM Semin Immunopathol; 2019 Jan; 41(1):49-58. PubMed ID: 30187086 [TBL] [Abstract][Full Text] [Related]
3. Advances in off-the-shelf CAR T-cell therapy. Benjamin R Clin Adv Hematol Oncol; 2019 Mar; 17(3):155-157. PubMed ID: 30969953 [No Abstract] [Full Text] [Related]
4. Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same Job. Schwerdtfeger M; Benmebarek MR; Endres S; Subklewe M; Desiderio V; Kobold S Curr Hematol Malig Rep; 2021 Apr; 16(2):218-233. PubMed ID: 33939108 [TBL] [Abstract][Full Text] [Related]
5. Adoptive cell therapy for acute myeloid leukemia. Ma H; Padmanabhan Iyer S; Parmar S; Gong Y Leuk Lymphoma; 2019 Jun; 60(6):1370-1380. PubMed ID: 30628504 [TBL] [Abstract][Full Text] [Related]
6. CAR T Cell Therapy for Neuroblastoma. Richards RM; Sotillo E; Majzner RG Front Immunol; 2018; 9():2380. PubMed ID: 30459759 [TBL] [Abstract][Full Text] [Related]
7. Immunobiology of chimeric antigen receptor T cells and novel designs. Walsh Z; Yang Y; Kohler ME Immunol Rev; 2019 Jul; 290(1):100-113. PubMed ID: 31355496 [TBL] [Abstract][Full Text] [Related]
8. Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance. Boyiadzis MM; Dhodapkar MV; Brentjens RJ; Kochenderfer JN; Neelapu SS; Maus MV; Porter DL; Maloney DG; Grupp SA; Mackall CL; June CH; Bishop MR J Immunother Cancer; 2018 Dec; 6(1):137. PubMed ID: 30514386 [TBL] [Abstract][Full Text] [Related]
9. Serving "a la CAR-T": Value-Based Pricing and Gene Therapy. Tempero M J Natl Compr Canc Netw; 2017 Oct; 15(10):1179. PubMed ID: 28982741 [No Abstract] [Full Text] [Related]
10. Engineering T cells for cancer: our synthetic future. Vonderheide RH; June CH Immunol Rev; 2014 Jan; 257(1):7-13. PubMed ID: 24329786 [No Abstract] [Full Text] [Related]
11. Adoptive T cell therapy: points to consider. Yee C Curr Opin Immunol; 2018 Apr; 51():197-203. PubMed ID: 29730057 [TBL] [Abstract][Full Text] [Related]
12. CAR-T Cells for Cancer Treatment: Current Design and Next Frontiers. Picanço-Castro V; Swiech K; Malmegrim KCR; Covas DT Methods Mol Biol; 2020; 2086():1-10. PubMed ID: 31707664 [TBL] [Abstract][Full Text] [Related]
14. T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition. Houot R; Schultz LM; Marabelle A; Kohrt H Cancer Immunol Res; 2015 Oct; 3(10):1115-22. PubMed ID: 26438444 [TBL] [Abstract][Full Text] [Related]
15. Engineering T cells for adoptive therapy: outsmarting the tumor. Kunert A; Debets R Curr Opin Immunol; 2018 Apr; 51():133-139. PubMed ID: 29579622 [TBL] [Abstract][Full Text] [Related]
16. Current landscape for chimeric antigen receptor T cells in lymphomas. Skarbnik AP Curr Opin Hematol; 2019 Nov; 26(6):421-426. PubMed ID: 31483334 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapy Approaches Beyond PD-1 Inhibition: the Future of Cellular Therapy for Head and Neck Squamous Cell Carcinoma. Qureshi HA; Lee SM Curr Treat Options Oncol; 2019 Mar; 20(4):31. PubMed ID: 30874960 [TBL] [Abstract][Full Text] [Related]
18. CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies. Knochelmann HM; Smith AS; Dwyer CJ; Wyatt MM; Mehrotra S; Paulos CM Front Immunol; 2018; 9():1740. PubMed ID: 30140266 [TBL] [Abstract][Full Text] [Related]
19. CAR-T Cell Therapy. Ahmad A Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560285 [TBL] [Abstract][Full Text] [Related]
20. T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance. Chandran SS; Klebanoff CA Immunol Rev; 2019 Jul; 290(1):127-147. PubMed ID: 31355495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]